Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
The importance of IL-33 in allergic inflammation.
Can we predict the evolution of an unpredictable disease like multiple sclerosis?
The role of KIR2DS1 in multiple sclerosis: KIR in Portuguese MS patients.
Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review.
Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study.
Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training.
Impact of oral health in patients with multiple sclerosis and epilepsy: A survey in a neurology clinic.
[Symptoms and clinical manifestations in neuromyelitis optica].
How do autoimmune diseases cluster in families? A systematic review and meta-analysis.
Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation.
Comparison of Intelligibility Measures for Adults with Parkinson's Disease, Multiple Sclerosis and Healthy Controls.
Pediatric familial neuromyelitis optica in two sisters with long term follow-up.
Glatiramer acetate-induced hepatitis in a patient with multiple sclerosis.
Temporal expression of growth factors triggered by epiregulin regulates inflammation development.
[Relationship between biochemical parameters of cerebrospinal fluid and the course of multiple sclerosis.]
Control of Human PLP1 Expression Through Transcriptional Regulatory Elements and Alternatively Spliced Exons in Intron 1.
Multiple sclerosis: CCSVI deconstructed and discarded.
Ultra-high-field MR imaging in multiple sclerosis.
[The clinical outcomes of idiopathic optic neuritis with no light perception in 21 eyes].
Biomechanical analysis of spasticity treatment in patients with multiple sclerosis.
Glucocorticoid treatment of multiple sclerosis.
Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis.
Pediatric multiple sclerosis: pathobiological, clinical, and magnetic resonance imaging features.
The use of valproic acid and multiple sclerosis.
Pages
« first
‹ previous
…
468
469
470
471
472
473
474
475
476
…
next ›
last »